[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f2oc9ats17qyrk":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":15,"applicant":16,"applicantSlug":17,"applNos":18,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":43,"exclusivities":44,"paragraphIv":45,"catalysts":47},"CEFAZOLIN SODIUM","HQ SPCLT PHARMA","hq-spclt-pharma",[19,20],"211413","216109","none",4,0,[25,33,38,41],{"key":26,"applNo":19,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"211413-001","001","POWDER","INTRAVENOUS","EQ 2GM BASE\u002FVIAL","2023-05-08","RX",{"key":34,"applNo":19,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":37,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"211413-002","002","EQ 3GM BASE\u002FVIAL","2024-03-08",{"key":39,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":40,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"216109-001","2022-10-07",{"key":42,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":40,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"216109-002",[],[],{"asOf":12,"firstFiled":12,"entries":46},[],[]]